A051301
|
Alliance
|
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A051701
|
Alliance
|
Randomized Phase II/III Study of Venetoclax (ABT 199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double-Expressing Lymphomas
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A051901
|
Alliance
|
Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
A051902
|
Alliance
|
A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A052101
|
Alliance
|
A Randomized Phase 3 Trial of Continuous vs Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A061402
|
Alliance
|
Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment with Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A062101
|
Alliance
|
A Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination with Iberdomide (CC-220)/Dexamethasone versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A062102
|
Alliance
|
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A071102
|
Alliance
|
A Phase II/III Randomized Trial Of Veliparib Or Placebo In Combination With Adjuvant Temozolomide In Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A071401
|
Alliance
|
Phase II Trial of SMO/AKT/NF2/CDK Inhibitors in Progressive Meningiomas with SMO/AKT/NF2/CDK Pathway Mutations
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|